type 1 diabetes

Peptides

GLP-1's Expanding Frontier: Type 1 Modeling and the Brown-Fat PET Surprise

GLP-1 receptor agonists keep pushing into new clinical territory. Two 2025 papers — a modeling review for type 1 diabetes and a case report where semaglutide lit up brown fat on a PET scan — hint at what's next.

Metabolic Health

The GLP-1 Pipeline: Triple Agonists, Older Adults, and the Cautious Move Toward Type 1

A wave of 2025 reviews and trial analyses sketches what comes after tirzepatide — broader populations, bigger weight-loss numbers, and tentative steps into autoimmune diabetes.